Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2012 · 10-Q
Revenue$3.06B$3.06B+13.9% vs Q1 2011 Net Income$277.30M$277.30M+10.0% vs Q1 2011 EPS Diluted$0.75$0.75+17.2% vs Q1 2011 Gross Profit$1,289,700,000+15.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flow$392,000,000+15.8% Free Cash Flowderived$322,800,000+17.4% Margins · derivedGross margin42.2%+0.6 pt vs Q1 2011
Operating margin11.8%−0.2 pt vs Q1 2011
Net margin9.1%−0.3 pt vs Q1 2011
ended Mar 31, 2012 · filed May 4, 2012 · 34 d after period end